Trials / Recruiting
RecruitingNCT05890781
Engineering Immune Organoids to Study Pediatric Cancer
Engineering Immune Organoids to Study Pediatric Cancer (IMMUNE-ORGANOIDS)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 108 (estimated)
- Sponsor
- Gustave Roussy, Cancer Campus, Grand Paris · Academic / Other
- Sex
- All
- Age
- 25 Years
- Healthy volunteers
- Not accepted
Summary
To engineer immune organoids from pediatric patient tissues using induced-pluripotent stem cells (iPSC)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Skin biopsy | Skin biopsy |
| PROCEDURE | Fresh tumor sample | Fresh tumor sample |
| BIOLOGICAL | Blood sample | Blood sample in heparin tubes (highly recommended), to be collected before starting treatment or as soon as hematological recovery has been reached |
| PROCEDURE | Healthy tissue from the tumor | Healthy tissue from the tumor site whenever possible |
| PROCEDURE | Spinal cerebrospinal fluid (SCF) | Spinal cerebrospinal fluid (SCF) whenever possible |
Timeline
- Start date
- 2023-05-12
- Primary completion
- 2028-05-01
- Completion
- 2028-05-01
- First posted
- 2023-06-06
- Last updated
- 2026-02-09
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05890781. Inclusion in this directory is not an endorsement.